Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Yizhe_Wang
|
| gptkbp:country |
gptkb:China
|
| gptkbp:focus |
developing and commercializing medicines in China and Asia
|
| gptkbp:foundedYear |
2019
|
| gptkbp:headquartersLocation |
gptkb:Shanghai
|
| https://www.w3.org/2000/01/rdf-schema#label |
LianBio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:BBP-398
gptkb:Nafamostat gptkb:TP-03 |
| gptkbp:partner |
gptkb:BridgeBio_Pharma
gptkb:Myokardia gptkb:Sierra_Oncology gptkb:Pfizer |
| gptkbp:stockExchange |
gptkb:Nasdaq
|
| gptkbp:stockSymbol |
gptkb:LIAN
|
| gptkbp:website |
https://www.lianbio.com/
|
| gptkbp:bfsParent |
gptkb:Apple_Tree_Partners
|
| gptkbp:bfsLayer |
6
|